Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1995-8-15
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0098-7484
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
26
|
pubmed:volume |
274
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
359
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:7541871-Adrenergic alpha-Antagonists,
pubmed-meshheading:7541871-Drug Synergism,
pubmed-meshheading:7541871-Drug Therapy, Combination,
pubmed-meshheading:7541871-Finasteride,
pubmed-meshheading:7541871-Humans,
pubmed-meshheading:7541871-Male,
pubmed-meshheading:7541871-Prazosin,
pubmed-meshheading:7541871-Prostatic Hyperplasia
|
pubmed:year |
1995
|
pubmed:articleTitle |
Combination drug therapy for benign prostatic hyperplasia.
|
pubmed:affiliation |
University of Iowa, Iowa City, USA.
|
pubmed:publicationType |
Journal Article
|